Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.41 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5599848 | 1.00 | GPR84 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL3839930 | 0.98 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL7557797 | 0.98 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL10010696 | 0.84 | CHRM1 (0.46) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL1713102 | 0.83 | FFAR4 (0.46) | GPR84FFAR1PPARDFFAR4 | |
| SCHEMBL10010150 | 0.81 | SLC1A2 (0.36) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL4002470 | 0.80 | MAPT (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL10923278 | 0.80 | MAPT (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL970515 | 0.80 | MAPT (0.59) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL527476 | 0.80 | MAPT (0.59) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2007039413-A | CRYSTAL COMPOSED OF (2S)-2-PROPENYLOCTANOIC ACID OR (2S)-2-PROPYNYLOCTANOIC ACID AND AMINE | ONO PHARMACEUT CO LTD | 2007-02-15 | — | — | JP | disclosed |
| EP-1078921-B1 | NOVEL INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF OPTICALLY ACTIVE OCTANOIC ACID DERIVATIVES | ONO PHARMACEUTICAL CO (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-6392073-B1 | IMPROVED OPTICAL PURITY OVER RECRYSTALLIZATION METHOD; 2.10 CAMPHORSULTAM DERIVATIVE | ONO PHARMACEUTICAL CO., LTD. (JP) | 2002-05-21 | — | — | US | disclosed |
| US-20020028947-A1 | Novel intermediates and processes for the preparation of optically active octanoic acid derivatives | ONO PHARMACEUTICAL CO., LTD. | 2002-03-07 | — | — | US | disclosed |
| US-6333415-B1 | N-(2S-(2-(PROPENYL OR PROPYNYL OR PROPYL)) OCTANOYL) (1S)-(-)-2,10-CAMPHORSULTAM, TO PREPARE 2S-(2-(PROPENYL OR PROPYNYL OR PROPYL)) OCTANOIC ACID, | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-12-25 | — | — | US | disclosed |
| EP-1078921-A1 | NOVEL INTERMEDIATES AND PROCESSES FOR THE PREPARATION OF OPTICALLY ACTIVE OCTANOIC ACID DERIVATIVES | ONO PHARMACEUTICAL CO., LTD. (JP) | 2001-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020028947-A1 | Novel intermediates and processes for the preparation of optically active octanoic acid derivatives | PDE6H, PDE6C, PDE6D | GPR84 1650/4885FFAR1 16/4885MAPT 2340/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.